To study the effect of the KDM4A/HIF1α/DDIT4/mTOR axis on NPC development, SUNE1 cells were treated with OE-KDM4A and treated with the mTOR pathway inhibitor everolimus. This evidence concerns the gene HIF1A and nasopharyngeal carcinoma.